High-risk borderline ovarian tumors: Analysis of clinicopathological features and prognostic impact of different follow-up strategies

Domenica Lorusso, Martina Ratti, Antonino Ditto, Francesco Raspagliesi

Research output: Contribution to journalArticle


Objectives: Borderline ovarian tumors (BOTs) represent 10-20% of all epithelial ovarian malignancies. Most of them are comparable to benign cysts but a high-risk group has been recognized. The aim of the study was to analyze different follow-up strategies in high-risk patients. Method: Patients with BOT treated at our institution from 1992 to 2011 were retrospectively reviewed. Clinicopathological features influencing prognosis were analyzed and two different follow-up strategies compared [6-month laparoscopic look (LPS-look): group A vs. ultrasound/CA-125 evaluation: group B]. Results: 70 patients with high-risk BOTs were identified. After a median progression-free survival (PFS) of 43 months, 27% of patients experienced recurrences. Six months after diagnosis, 26 high-risk patients were submitted to LPS-look: at surgery, 6 out of 10 patients presenting evidence of disease were optimally debulked while in the remaining 4, only biopsies were performed. No difference in PFS was registered between group A and B patients, nevertheless a significant increase in PFS was registered among completely versus incompletely debulked patients with evidence of disease at laparoscopy. Conclusion: Clinical follow-up remains the gold standard for BOTs. These very preliminary data seem to suggest that LPS-look may have an impact on the secondary PFS in a subgroup of high-risk patients.

Original languageEnglish
Pages (from-to)183-192
Number of pages10
Issue number3
Publication statusPublished - 2014



  • Borderline ovarian tumor
  • BOT
  • Laparoscopy
  • treatment and follow-up

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this